Celularity, Inc. (CELU)
1.33
+0.02
(+1.53%)
USD |
NASDAQ |
Oct 15, 16:00
Celularity Cash from Operations (TTM) : -8.814M for March 31, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -8.814M |
| December 31, 2025 | -13.25M |
| September 30, 2025 | -6.557M |
| June 30, 2025 | -2.542M |
| March 31, 2025 | -4.991M |
| December 31, 2024 | -6.401M |
| September 30, 2024 | -12.34M |
| June 30, 2024 | -20.51M |
| March 31, 2024 | -28.09M |
| December 31, 2023 | -38.68M |
| September 30, 2023 | -63.93M |
| June 30, 2023 | -93.33M |
| March 31, 2023 | -118.62M |
| Date | Value |
|---|---|
| December 31, 2022 | -137.88M |
| September 30, 2022 | -140.34M |
| June 30, 2022 | -137.39M |
| March 31, 2022 | -119.27M |
| December 31, 2021 | -110.10M |
| September 30, 2021 | -94.88M |
| June 30, 2021 | -105.70M |
| March 31, 2021 | -87.72M |
| December 31, 2020 | -63.19M |
| September 30, 2020 | -46.59M |
| June 30, 2020 | -1.677M |
| March 31, 2020 | -1.647M |
| December 31, 2019 | -1.098M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Tenax Therapeutics, Inc. | -46.03M |
| Exicure, Inc. | -6.704M |
| Century Therapeutics, Inc. | -86.74M |
| Absci Corp. | -108.08M |
| Cardio Diagnostics Holdings, Inc. | -5.660M |